Ligand validation:4BUQ

KGM: heptyl alpha-D-mannopyranoside

KGM is a Ligand Of Interest in 4BUQ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4BUQ_KGM_B_201	56%	65%	0.155	0.926	0.63	0.72	-	-	0	0	100%	1
4BUQ_KGM_A_201	52%	55%	0.163	0.922	0.98	0.76	1	-	0	0	100%	1
4LOV_KGM_A_201	98%	28%	0.049	0.974	1.35	1.54	3	3	0	0	100%	1
5FS5_KGM_A_1159	95%	54%	0.066	0.972	0.9	0.89	1	-	0	0	100%	1
4XOC_KGM_A_501	94%	64%	0.076	0.974	0.6	0.79	-	-	0	0	100%	1
4CA4_KGM_A_201	23%	34%	0.293	0.92	1.18	1.41	2	2	0	0	100%	0.42
4XOB_KGM_A_301	41%	56%	0.233	0.95	0.8	0.9	-	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.